Equity Research, Broker Reports, and media content on Beximco Pharmaceuticals Ltd.

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Beximco Pharmaceuticals Ltd.
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Beximco Pharmaceuticals Ltd.

Company Profile

  • Personnel
  • Ahmed Sohail Fasiur Rahman, Chairman
  • Nazmul Hassan, CEO
  • Ali Nawaz, CFO

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Beximco Pharmaceuticals Ltd.. We currently have 50 research reports from 3 professional analysts.

  • Open: 57.5p
  • Range Today: 56.0/60.0p
  • 52 Week: 30.9/81.4p
  • Daily Volume: 22.5k
  • Daily Liquidity: (0.01%)
  • # Shares: 405.6m
  • Market Cap: £233.2m
  • Latest PE (hist): 0.00
  • Div Yield: 1.92
Date Source Announcement
21Sep20 07:00 RNS Beximco Pharma receives eighth FDA approval
28Aug20 11:06 RNS Second Price Monitoring Extn
28Aug20 11:00 RNS Price Monitoring Extension
28Aug20 08:31 RNS Beximco and SII to cooperate on a COVID-19 vaccine
30Jul20 07:00 RNS Board Change
23Jun20 07:00 RNS Q3 Financial Results and Business Update
21May20 07:00 RNS World’s first generic remdesivir for COVID-19
  • Frequency of research reports

     

  • Research reports on

    Beximco Pharmaceuticals Ltd.

  • Providers covering

    Beximco Pharmaceuticals Ltd.